Testosterone replacement therapy and prostate cancer: A word of caution

Timothy C. Brand, Edith Canby-Hagino, Ian M. Thompson

Resultado de la investigación: Articlerevisión exhaustiva

24 Citas (Scopus)


The number of men for whom testosterone is prescribed is rapidly Increasing. The aging man normally demonstrates a gradual decline in testosterone. Symptoms of hypogonadism include erectile dysfunction, diminished libido, sarcopenia, increased adiposity, osteopenia and osteoporosis, impaired cognition, and depression. There is a paucity of data regarding both efficacy and safety of testosterone replacement therapy. Testosterone levels have been shown to modulate prostate cancer risk and progression. A prospective evaluation of prostate cancer risk with testosterone replacement therapy has not been conducted. We outline concerns and recommendations for the use of testosterone replacement therapy in the aging man.

Idioma originalEnglish (US)
Páginas (desde-hasta)185-189
Número de páginas5
PublicaciónCurrent urology reports
EstadoPublished - may 1 2007

ASJC Scopus subject areas

  • Urology


Profundice en los temas de investigación de 'Testosterone replacement therapy and prostate cancer: A word of caution'. En conjunto forman una huella única.

Citar esto